Detailed answers about IMMUNO-ONCOLOGY CLINICAL NETWORK, including incorporation, status, business activity, and accounts information.
When was IMMUNO-ONCOLOGY CLINICAL NETWORK founded?
IMMUNO-ONCOLOGY CLINICAL NETWORK was officially incorporated on 10 October 2023 and is registered under company number CE033863. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is IMMUNO-ONCOLOGY CLINICAL NETWORK?
Charitable Incorporated Organisation. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of IMMUNO-ONCOLOGY CLINICAL NETWORK?
IMMUNO-ONCOLOGY CLINICAL NETWORK's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What is IMMUNO-ONCOLOGY CLINICAL NETWORK's registered address?
The registered office address of IMMUNO-ONCOLOGY CLINICAL NETWORK is . This is the official address filed with Companies House for legal and statutory correspondence.
Is IMMUNO-ONCOLOGY CLINICAL NETWORK financially stable?
Financial accounts for IMMUNO-ONCOLOGY CLINICAL NETWORK are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.